Agape ATP Co. (NASDAQ:ATPC - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 283,200 shares, a growth of 297.2% from the March 31st total of 71,300 shares. Approximately 1.5% of the shares of the company are sold short. Based on an average trading volume of 2,020,000 shares, the days-to-cover ratio is presently 0.1 days.
Agape ATP Stock Performance
NASDAQ ATPC traded down $0.12 on Wednesday, hitting $2.30. 88,042 shares of the stock were exchanged, compared to its average volume of 1,744,334. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.59 and a quick ratio of 3.53. The business's fifty day moving average is $1.37 and its 200 day moving average is $1.39. Agape ATP has a 52 week low of $0.90 and a 52 week high of $8.00. The company has a market capitalization of $115.01 million, a PE ratio of -3.15 and a beta of 0.40.
Agape ATP (NASDAQ:ATPC - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.20) earnings per share for the quarter. The company had revenue of $0.36 million during the quarter. Agape ATP had a negative net margin of 194.09% and a negative return on equity of 74.71%.
About Agape ATP
(
Get Free Report)
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.
Further Reading
Before you consider Agape ATP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agape ATP wasn't on the list.
While Agape ATP currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.